Wolfe Research analyst Nigel Coe downgrades Vertiv Holdings (NYSE:VRT) from Outperform to Peer Perform.
Raymond James Maintains Outperform on CME Group, Raises Price Target to $240
Raymond James analyst Patrick O'Shaughnessy maintains CME Group (NASDAQ:CME) with a Outperform and raises the price target from $230 to $240.